SenoRx Income Statement
View: Annual
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 35.0 | 25.5 | 19.3 |
| Cost of Goods Sold | 15.1 | 13.5 | 10.1 |
| Gross Profit | 19.9 | 12.0 | 9.1 |
| Gross Profit Margin | 56.8% | 47.0% | 47.5% |
| SG&A Expense | 27.8 | 20.0 | 14.6 |
| Depreciation & Amortization | 1.8 | 2.4 | 2.5 |
| Operating Income | (9.6) | (10.4) | (8.0) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 1.4 | (4.0) | 0.1 |
| Nonoperating Expenses | 1.6 | 1.0 | 0.7 |
| Income Before Taxes | (9.9) | (15.4) | (8.6) |
| Income Taxes | -- | -- | 0.0 |
| Net Income After Taxes | (9.9) | (15.4) | (8.6) |
| Continuing Operations | (9.9) | (15.4) | (8.6) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (9.9) | (15.4) | (8.6) |
| Total Net Income | (9.9) | (15.4) | (8.6) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.75) | (6.61) | (1.20) |
| Dividends per Share | -- | -- | -- |





